By targeting three key growth pathways at once, researchers eliminated pancreatic tumors in multiple mouse models and ...

A national clinical trial led by the Alliance for Clinical Trials in Oncology has found that oxybutynin, a drug often used to ...

The FDA has granted orphan drug designation to IFx-2.0 for patients with stage 2B to stage 4 cutaneous melanoma. The U.S. Food and Drug Administration (FDA) has granted orphan drug designation to the ...

No longer confined to cancer centers, skin complications of cancer therapies are now commonly encountered at the community ...

Immunotherapy has transformed cancer care by helping the immune system recognize and destroy tumors. But new research from ...

Fury over decision to axe ‘last hope’ cancer treatment from NHS - It’s being called a ‘backward step for NHS care’ ...

TuHURA Biosciences, Inc. (NASDAQ:HURA) ("TuHURA" or the "Company"), a Phase 3 immuno-oncology company developing novel therapeutics to overcome resistance to cancer immunotherapy, today announced that ...

A curious phenomenon seen by oncologists, that morning patients do better than those receiving afternoon infusions, gains ...

The fear that a biopsy can spread cancer continues to delay diagnosis and treatment. Oncologists explain why biopsy is safe, ...

Researchers found an antibody that seems to play a role in people with better lung cancer prognoses, but turning it into a ...

A scientific study suggests that weight loss drugs could reduce the risk of several cancers associated with obesity.

While exemptions on key imported cancer therapies promise reduced treatment costs for patients, oncologists say preventing ...